ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
41 hedge funds and large institutions have $4.58M invested in Oncternal Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 14 closing their positions.
Holders
41
Holders Change
-11
Holders Change %
-21.15%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
8
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Millennium Management
New York
|
$1.1M |
2 |
PPW
2
Pasadena Private Wealth
Pasadena,
California
|
$268K |
3 |
3
Morgan Stanley
New York
|
$99.7K |
4 |
4
Citadel Advisors
Miami,
Florida
|
$29.1K |
5 |
TSS
5
Two Sigma Securities
New York
|
$31.5K |